Market capitalization | $1.70b |
Enterprise Value | $1.79b |
P/E (TTM) P/E ratio | 103.99 |
EV/FCF (TTM) EV/FCF | 9.82 |
EV/Sales (TTM) EV/Sales | 2.26 |
P/S ratio (TTM) P/S ratio | 2.14 |
P/B ratio (TTM) P/B ratio | 2.34 |
Revenue growth (TTM) Revenue growth | 5.61% |
Revenue (TTM) Revenue | $792.32m |
As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.
18 Analysts have issued a GoodRx Holdings forecast:
18 Analysts have issued a GoodRx Holdings forecast:
Dec '24 |
+/-
%
|
||
Revenue | 792 792 |
6%
6%
|
|
Gross Profit | 675 675 |
13%
13%
|
|
EBITDA | 158 158 |
39%
39%
|
EBIT (Operating Income) EBIT | 88 88 |
330%
330%
|
Net Profit | 16 16 |
285%
285%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform. The firm offers information and tools to help consumers compare prices for prescription drugs. It operates applications and websites that provide prices and discounts at local and mail-order pharmacies. The company was founded in September 2015 and is headquartered in Santa Monica, CA.
Head office | United States |
CEO | Wendy Barnes |
Employees | 738 |
Founded | 2015 |
Website | www.goodrx.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.